1. Introduction {#sec1}
===============

*Qian Ceng Ta*, the whole plant of *Huperzia serrata* (*H. serrata*), was an important Traditional Chinese Herbs (TCH) for the treatment of contusions, strains, swellings, schizophrenia, myasthenia gavis, and organophosphate poisoning since Tang Dynasty \[[@bib1],[@bib2]\]. Huperzine A (HupA), a representative lycodine-type lycopodium alkaloid, was first isolated and identified by Chinese scientist in 1986 \[[@bib2]\] and was found as a powerful, highly specific, and reversible acetylcholinesterase inhibitors \[[@bib3],[@bib4]\]. This natural product has attracted widespread attention because of its unique pharmacological activities and low toxicity. Owing to the low content of HupA, slow growth of the plant, and no plant culture method for this plant, the supply for this compound is not sustainable \[[@bib5]\]. Producing the lycopodium alkaloids in heterologous host by using synthetic biology is an alternative method, because this method has been successful to produce ginsenoside in yeast \[[@bib6]\] and artemisinin in tobacco \[[@bib7]\].

The biosynthetic pathway of HupA has been proposed based on labeled precursors feeding experiment by Ma and Gang \[[@bib4]\]. Lysine/Ornithine decarboxylase (L/ODC) was proposed as the first enzyme for HupA biosynthesis. Indeed, L/ODC could catalyze the first-step in the biosynthesis pathway of lysine-derived alkaloids in different lycopodium plants \[[@bib8], [@bib9], [@bib10]\]. After the decarboxylation of lysine to produce cadaverine, it would be catalyzed by copper amine oxidase (CAO) to yield 5-aminopentanal, which is spontaneously cyclized to the first intermediate for lysine-derived alkaloids production, Δ1-piperideine \[[@bib11]\]. However, the genes involved in the skeleton formation and modification are still unclear. Although some candidate genes for HupA biosynthesis were proposed based on the EST data and the global RNA-Seq data from *H. serrata*, none was characterized because of the lack knowledge of substrate and intermediates involved in HupA biosynthesis.

Metabolomics, focusing on the high-throughput qualitative and quantitative profiling of small molecular metabolites, has been used for the candidate genes mining and characterization by integrating with other omics \[[@bib12]\]. In the past years, targeted metabolomics has been used for the detection of HupA in different lycopodium plants base on high-performance liquid chromatography (HPLC) to find the better sources than *H. serrata* \[[@bib13]\]. To improve the efficiency of extraction and detection, an high performance liquid chromatography coupled with mass spectrometry (HPLC-MS) based method was developed for HupA detection, identification and quantification \[[@bib14]\]. However, these works only focused on the content of HupA. Subsequently, another ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) based metabolomics method was developed and 27 lycopodium alkaloids were identified, of which only six metabolites were identified based on comparison of accurate MS and MS/MS data compared to the authentic standards \[[@bib5]\]. Currently, more than 200 lycopodium alkaloids have been isolated and identified by NMR \[[@bib4]\]. Given the limited authentic standards and recruited lycopodium alkaloids in the public databases, and limited reference MS/MS spectra, only few could be identified by commonly used tools. In addition, many lycopodium alkaloids had the same formula and skeleton, thus the MS and MS/MS spectra are similar, making it more difficult to identify. Combination of the computational tools will be more useful for the identification because the identification based on these tools were independent on the public databases.

In this study, a comprehensive relative quantitative metabolomics method for the extraction, detection and identification of lycopodium alkaloids in different tissues of *H. serrata* was firstly developed. For identification, a computational tool based lycopodium alkaloids specific in-house database was developed and identified118 putative chemicals. In addition, other computational software was also employed to dereplicate the structure of lycopodium alkaloids and identified the peak3585 to N-methylhuperzine A based on the in-silico fragmentation pattern.

2. Materials and methods {#sec2}
========================

2.1. Plant materials {#sec2.1}
--------------------

The plants were collected from Xiangxi, Hunan, China, in January 2017. The plants were carefully rinsed in running tap water, and soil was removed by hand. Root, stem, and leaf were separated from the plant and ground to fine power in liquid nitrogen and ice-dried, and then stored at-80 °C until further using.

2.2. Authentic standards {#sec2.2}
------------------------

The authentic standards of huperzine A, huperzine B (HupB), Lycoposerramine C (Lycop C) and lycoposerramine D (Lycop D) were separated from the crude alkaloids extracted from *H. serrata* and identified by NMR ([Supplementary method](#appsec1){ref-type="sec"}) according to previous reports \[[@bib2],[@bib15]\]. All purified authentic standards (\>95% purity, [Supplementary Figs. S1, S2](#appsec1){ref-type="sec"}) were dissolved in methanol with 100 ng/mL, filtered through 0.22 μM PTEE filters and stored at −20 °C until for using.

2.3. Lycopodium alkaloids extraction {#sec2.3}
------------------------------------

The extraction of lycopodium alkaloids was carried out according to previous report with minor modification \[[@bib16]\]. Around twenty mg dry power was weighted and extracted by 1 mL methanol including 0.1% (v/v) formic acid. After adding 400 ng caffeine as internal standard, the sample was sonicated for 15 min at room temperature. Centrifugation at 17000*g* for 10 min, the supernatants were filtered through 0.22 μM PTEE filters and then analyzed by UPLC-MS. Meanwhile, the blank samples were also treated with the same procedure. All samples including the blank were repeated three times.

2.4. Analytical platform {#sec2.4}
------------------------

A waters Ultra performance liquid chromatography system (Waters Corporation, Milford, MA, USA) was used. That system was coupled to a Thermo Scientific Q-Exactive mass spectrometer equipped with a HESI interface (Thermo Scientific, Hemel Hempstead, U.K.). Thermo Xcalibur Tune software (version 3.0) was used for instrument control and data acquisition.

The separation was performed with a Waters Acquity HSS T3 C18 column (150 mm × 2.1 mm, i.d. 1.8 μm) in positive mode ESI. A linear biphasic LC gradient was conducted from 2% to 60% B over 12 min, and then kept at this phase for 2 min, followed by 3 min wash with linear biphasic gradient from 60% B to 2% B over 1 min, and 3 min re-equilibration with 2% B, where solvent A was 0.1% formic acid in water and solvent B was acetonitrile. The flow rate was 0.25 mL/min, column temperature was maintained at 30 °C, injection volume was 2 μL, and samples were maintained at 4 °C in the autosampler.

2.5. Data processing {#sec2.5}
--------------------

The raw data files were firstly converted to mzXML format files and mzML format files using MSConvert \[[@bib17]\]. After peak deconvolution and alignment processing by XCMS \[[@bib18],[@bib19]\] and MS-DIAL \[[@bib20]\], the given peak alignment table was further used to choose the true peaks before putative identification based on four-step filtration ([Fig. 1](#fig1){ref-type="fig"}) according to the previous method \[[@bib21]\]. The filtered peaks were used for putative identification in different databases by using precursor ions (*m/z*) and/or MS/MS spectrum based on different software, xMSannotator \[[@bib22]\], Metabosearch \[[@bib23]\], and MS-DIAL \[[@bib20]\]. Here, an in-house database for lycopodium alkaloids in *H. serrata* was also developed based on the computational tool, plantMAT \[[@bib24]\]. Furthermore, MS-FINDER \[[@bib25]\] and CSI:FingerID \[[@bib26]\], were used for the prediction of in-silico fragmentations.Fig. 1The strategy of LC-MS-based comprehensive metabolomics analysis. The four-step filtration was carried out as described \[[@bib21]\].Fig. 1

After processing by MS-DIAL \[[@bib20]\], a plot view was shown and each plot was a detected peak. The information of spectrum, retention time, *m*/*z* value, and so on could be shown by left click. The interested peak (plot) could be linked to MS-FINDER \[[@bib25]\] for exact identification by in-silico fragmentation pattern by right click. More details could refer to the manual tutorial (<http://prime.psc.riken.jp/Metabolomics_Software/MS-DIAL/MS-DIAL%20tutorial_vs9.pdf>).

2.6. Chemicals identification {#sec2.6}
-----------------------------

All peaks processed by XCMS were directly submitted to our in-house database for putative identification. After the identification by this in-house database, we could get the possible chemotypes and related constituents for each peak, and then the putatively identified peaks were submitted to MS-FINDER for exact identification by in-silico fragmentation pattern. Using these two steps analysis, the peak could be exactly identified including the chemotype and constituents.

2.7. Statistical analysis and visualization {#sec2.7}
-------------------------------------------

The putatively identified peaks was listed in a csv file and then submitted to the web-based tool, MetaboAnalyst \[[@bib27]\], for statistical analysis and visualization by using the default parameters.

3. Results and discussion {#sec3}
=========================

Owing to the complex of the lycopodium alkaloids biosynthesis network and limited genomic data, HupA biosynthetic pathway was still unclear although the proposed pathway had been published in 2004 based on feeding experiment \[[@bib4]\]. To further elucidating HupA biosynthetic pathway, the transcriptomes were determined and mined candidate genes. However, these candidate genes were still not characterized with the exception of *L/ODC* \[[@bib8], [@bib9], [@bib10]\] and *CAO* \[[@bib11]\]. Metabolomics coupled with transcriptomics was an efficient way to mine and characterize the candidate genes. For example, glycyrrhizin biosynthetic pathway was almost fully elucidated by using the metabolomics-based analysis \[[@bib28], [@bib29], [@bib30]\]. Although more than 100 lycopodium alkaloids in *H. serrata* had been identified by NMR \[[@bib31]\], the contents and distribution in different tissues were still unknown. For the comparison between different tissues or different individuals, absolutely quantitative metabolomics analysis is not necessary \[[@bib32]\]. Hence, the comprehensive relative quantitative metabolomics analysis of the lycopodium alkaloids in different tissues of *H. serrata* was firstly performed in current study.

3.1. Analysis of the lycopodium alkaloid profiling in *H. serrata* {#sec3.1}
------------------------------------------------------------------

All samples from different tissues (root, stem, and leaf) were first extracted by the buffer of 0.1% formic acid in methanol and then analyzed in positive mode ESI \[[@bib16]\]. In this case, the main peaks extracted from three tissues were mainly present at the retention time from 3 min to 8 min ([Fig. 2](#fig2){ref-type="fig"}A). After the data processing by MS-DIAL \[[@bib20]\], the plot viewer also supported this point ([Fig. 2](#fig2){ref-type="fig"}B). The plot labeled with the blank circle (*m/z* = 243.14919, *t*~R~ = 4.79 min) which was identified as the HupA by authentic standard ([Fig. 3](#fig3){ref-type="fig"}A) was also located in these region ([Fig. 2](#fig2){ref-type="fig"}C). It suggested the lycopodium alkaloids were mainly separated in the time-window from 3 min to 8 min by using our LC separation method, which could give a suggestion how to optimize the LC separation method to efficiently separate the lycopodium alkaloids.Fig. 2Metabolite profiling of lycopodium alkaloids in leaf, stem, and root. (A) Total ion chromatography map of the lycopodium alkaloids in different tissues. (B) plot view of the peaks was processed by the software of MS-DIAL \[[@bib20]\]. (C) Magnified plot view of (B) to showed the labeled plot. *t*~R~ ranged from 4.2 min to 5.3 min, and *m/z* value ranged from 220 Da to 270 Da. The plot labeled with black circle was HupA that was subsequently identified by chemical standard as shown in [Fig. 3](#fig3){ref-type="fig"}A.Fig. 2Fig. 3Extracted ion maps (EIC) of identified peaks by authentic standards in different tissues of *H. serrata*. (A) HupA at *t*~R~ = 4.79 min extracted with *m/z* = 243.14919, peak4297 at *t*~R~ = 4.54 min was also extracted with *m/z* = 243.14919; (B) HupB at *t*~R~ = 4.37min extracted with *m/z* = 257.16484, peak4360 at *t*~R~ = 4.91 min was also extracted with *m/z* = 257.16484; (C) The internal standard of caffeine at *t*~R~ = 5.34 extracted with *m/z* = 195.08765; (D) Lycop C at *t*~R~ = 4.94 min extracted with *m/z* = 262.18016; (E) Lycop D at *t*~R~ = 5.28 min extracted with *m/z* = 292.19072, this metabolite perhaps not present in root or the content was lower than the limit of determination.Fig. 3

Here, the four authentic standards and the internal standard were all identified in the tissues of leaf and stem. For the tissue of root, Lycop D was likely not present or the content of the compound in this tissue was lower than the determination limitation in this instrument. The lycodine-type lycopodium alkaloids (HupA and Hup B) could be shown earlier than fawcettimine-type lycopodium alkaloids (Lycop C and Lycop D) in our LC separation system. Similarly, Lycopodine, the lycopodine-type lycopodium alkaloid, had the later retention time than HupA \[[@bib5]\]. The internal standard (IS), caffeine (*t*~R~ = 5.34), was totally different type alkaloid with the lycopodium alkaloids, and separated later than all the four lycopodium alkaloids, indicating that different types lycopodium alkaloids could be separated at different time-windows during the separation.

3.2. Data processing and putative metabolite identification {#sec3.2}
-----------------------------------------------------------

The file formats of mzXML and mzML are standardization initiatives \[[@bib22],[@bib24]\], and could be submitted to the two commonly used metabolomics data analysis software of XCMS \[[@bib18],[@bib19]\] and mzMine 2 \[[@bib33]\] for deconvolution and alignment analysis. XCMS Online \[[@bib34]\] was a useful web-based tool for metabolomics data analysis automatically, including peak deconvolution, alignment, putative identification, statistical analysis, and pathway enrichment after submitting the raw data less than 25 Gb size. In addition, mzMine 2 \[[@bib33]\] was another useful tool for metabolomics analysis and putative identification based on different databases, especially the ADAP algorithm that could reduce the false positive and false negative peak picking from XCMS \[[@bib35]\]. However, these two tools were not convenient for our study because the former one was not allowed to download the identified result, and the later one was need higher computer configuration and required additional Java and R language platform to perform the ADAP algorithm. Here, we used two R packages, XCMS and CEMARE, to process the metabolomics data and resulted more than 15000 peaks as the described parameters \[[@bib36]\]. To pick up the true peaks, four-step filtration was carried out as described \[[@bib21]\] and resulted 2354 true peaks including the five chemicals identified by authentic standards, indicating that the four-step filtration was useful to get the true peaks.

The contents of the identified lycopodium alkaloids were firstly calculated based on the internal standard ([Fig. 4](#fig4){ref-type="fig"}). Comparing with root, the content of the four chemicals was significantly higher in stem and leaf, and the four chemicals had same tendency. The distribution of HupA was consistent with the previous study \[[@bib13]\]. In addition, the content of HupA was not the most abundant one even in the four identified chemicals, suggesting the complex of the HupA biosynthetic pathway. Meanwhile, the true peaks were used for putative identification by different databases, KEGG, HMDB, LipidMAPS, T3DB, and CCMD, based on the software of MetaboSearch \[[@bib23]\] and xMSannotaor \[[@bib22]\] ([Table 1](#tbl1){ref-type="table"}). Among these databases, caffeine could be identified by KEGG, HMDB, and T3DB, and HupB was only identified by KEGG. Interestingly, HupB could be identified by CCMD using exact *m/z* value but the retention time is not matched. Other three chemicals could not be identified by these databases. It suggested that most lycopodium alkaloids in *H. serrata* are not recruited in these commonly used databases. MS-DIAL \[[@bib20]\] could also be used for data processing and putative identification based on multiple MS/MS banks. Thus, we tried to putatively identify the lycopodium alkaloids based on the MS/MS bank directly using this software. Similarly, only caffeine could be identified by the MS/MS banks of MassBank, GNPS and Respect. It was reasonable that most the lycopodium alkaloids were not recruited by public databases and MS/MS banks. In another word, the current commonly used public MS/MS banks and databases were not suitable for the putative identification of lycopodium alkaloids in *H. serrata*.Fig. 4The contents of identified chemicals in different tissues. \*means that significant differences between leaf and stem comparing with root (*P* \< .05). Three biological duplicates were performed.Fig. 4Table 1The value of different databases for lycopodium alkaloids identification.Table 1NameKEGGHMDBLipidMAPST3DBCCMDMS-DIALin-house databaseHuperzine ANoNoNoNoNoNoYesHuperzine BYesNoNoNo\*NoYesCaffeine (IS)YesYesNoYesNoYesYesLycoposerramine CNoNoNoNoNoNoYesLycoposerramine DNoNoNoNoNoNoYes[^1][^2]

As mentioned above, the lycopodium alkaloids specific database is pivotal for the putative identification of lycopodium alkaloids. PlantMAT \[[@bib24]\], a computational tool based on combinatorial enumeration of metabolic building blocks, was developed to further identifying the specialized metabolites that there was no authentic standards or not recruited in public databases. Using this tool, we built a lycopodium alkaloids specific in-house database for putative identification. All the five identified chemicals could be identified by this in-house database ([Table 1](#tbl1){ref-type="table"}), indicating that this in-house database was helpful for our study. Totally, 118 lycopodium alkaloids were putatively identified by this in-house database ([Table 2](#tbl2){ref-type="table"}). Nevertheless, most of the peaks could be identified to multiple metabolite names even using both MS spectrum and MS/MS spectrum. Thus, the peak number derived from XCMS alignment table was still kept for further analysis.Table 2Putatively identified peaks by in-house database.Table 2

3.3. Statistical analysis and in-silico fragmentations prediction {#sec3.3}
-----------------------------------------------------------------

The contents of the 118 putatively identified peaks were calculated by the content of internal standard, and then submitted to MetaboAnalyst \[[@bib27]\] for statistical analysis and visualization. Principle component analysis (PCA) and partial least squares−discriminant analysis (PLS-DA) were two commonly used algorithms to analyze the metabolic profiling derived from different samples. PCA and PLS-DA plot showed the same result: metabolite profiling of three tissues were separated obviously by the first component ([Fig. 5](#fig5){ref-type="fig"}A, C), and peak4388 and peak3954 were metabolite biomarkers for the three tissues ([Fig. 5](#fig5){ref-type="fig"}B, D, [Supplementary Dataset S1, S2](#appsec1){ref-type="sec"}). The content of these two peaks were significantly higher in leaf and stem than in root ([Fig. 6](#fig6){ref-type="fig"}), and the contents of these two peaks were also significantly higher than HupA content ([Fig. 3](#fig3){ref-type="fig"}). Among the 118 identified peaks, 72 peaks were significantly different among three different tissues (*P* \< .05). Subsequently, the Pearson correlation analysis of the identified peaks was performed and all these peaks could be separated to 2 totally different groups ([Fig. 7](#fig7){ref-type="fig"}). Of which, the four identified lycopodium alkaloids and the two metabolite biomarkers of peak4388 and peak3954 were the same group with HupA. Nearly 70% of the peak had positive correlation, and these peaks were almost positively with HupA, suggesting that these peaks might participate in the biosynthesis and modification of HupA.Fig. 5PCA and PLS-DA plots. (A) PCA score plot of different tissues; (B) PCA loading plot of different tissues; (C) PLS-DA score plot of different tissues; (D) PLS-DA loading plot of different tissues. HsRt, HsSt and HsLf means the tissues of root, stem and leaf, respectively. Three replicates were used.Fig. 5Fig. 6The contents and distribution of peak4388 and peak3954 in root, stem, and leaf.Fig. 6Fig. 7The Pearson correlation of identified peaks. The peaks labeled with yellow square were the identified peaks by authentic standards and two metabolite biomarkers.Fig. 7

Given the limited authentic standards for lycopodium alkaloids, the predictive computational tools could be helpful for more efficient and accurate structure dereplication and prediction. CSI:FingerID \[[@bib26]\], a tool to identify chemical structures without search spectral libraries, enabled to predict unknown structures by machine learning of MS/MS data. There are four skeleton type lycopodium alkaloids in lycopodium plants, thus the fragments pattern will be similar for the chemicals with the same skeleton. Currently, we know nothing about the fragmentation patterns of lycopodium alkaloids even the identified HupA. Hence, HupA was first used to predict the fragmentation pattern of lycodine-type lycopodium alkaloids by this tool. As shown in [Fig. 8](#fig8){ref-type="fig"}A, the precursor ion of 243.1489 would form two fragmentations, *m/z* = 226.1225 and *m/z* = 197.0835, and the fragmentation of *m/z* = 197.0835 could further form other fragmentations. Combining the fragmentation pattern and spectra, we predicted the three major fragmentations of HupA at *m/z* = 243.14862, 226.12219, and 198.09099, and the last two fragmentations were derived from the precursor fragmentation *m/z* = 243.14862 ([Fig. 8](#fig8){ref-type="fig"}B). The relative abundance of the three fragmentations could be used for lycodine-type alkaloids identification.Fig. 8Possible fragmentation pattern of HupA. (A) Fragmentation pattern predicted by CSI:FingerID; (B) Spectra and three predicted fragmentations of HupA.Fig. 8

Usually, the losses of some functional groups could introduce the hydrogen rearrangement, making it was more difficult to distinguish the true spectra. MS-FINDER \[[@bib25]\] could also be used for predict the structure of unknown metabolites based on exactly analysis the MS/MS data and considering the hydrogen rearrangement rule. In addition, this tool could process the data derived from MS-DIAL. Namely, this tool could automatically recognize the experimental MS/MS spectrum and produce the in-silico fragmentations. Thus, we processed the data with MS-DIAL and then submitted HupA to MS-FINDER as the tutorial for fragmentation prediction. Similarly, the fragmentation pattern was the same as the former predicted one ([Fig. 9](#fig9){ref-type="fig"}A). Using this in-silico fragmentation pattern, it was easy to find which function group was lost. The fragmentation pattern ([Fig. 9](#fig9){ref-type="fig"}C) and experimental spectrum or in-silico spectrum ([Fig. 9](#fig9){ref-type="fig"}D) of peak3585 were similar with HupA, indicating this compound is HupA related. According the in-silico spectra, precursor of peak3585 had a more group of \[CH3\] than HupA, thus it predicted to be methyl-huperzine A. When identifying using our in-house database, N-methylhuperzine A was a candidate, thus peak3585 should be N-methylhuperzine A. It indicated integrating our in-house database and MS-FINDER is more efficient for the lycopodium alkaloids identification.Fig. 9Possible fragmentation pattern of HupA and peak3585. (A) Fragmentation pattern of HupA predicted by MS-FINDER; (B) Comparison between experimental spectrum and in-silico spectrum of HupA; (C) Fragmentation pattern of peak3585 predicted by MS-FINDER; (D) Comparison between experimental spectrum and in-silico spectrum of peak3585.Fig. 9

In summary, a comprehensive metabolomics method was developed and could be used to separate different types of lycopodium alkaloids at different time-windows. Meanwhile, the developed in-house database was a useful tool to identify lycopodium alkaloids. Integration of the in-house database and the computational tool MS-FINDER could be used for identification of lycopodium alkaloids.

4. Conclusion {#sec4}
=============

In current study, we built a UPLC-MS strategy for the comprehensive metabolomics analysis for lycopodium alkaloids in different tissues of *H. serrata*. Here, a computational method based in-house database was developed and putatively identified 118 lycopodium alkaloids. Integrating our in-house database and another computational tool, MS-FINDER, could dereplicate the structure of the peak3585 to N-methylhuperzine A without the authentic standard. This strategy could help us to identify more lycopodium alkaloids.
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[^1]: No, means the metabolite was not identified by this database using *m/z* value and retention time.

[^2]: Yes, means the metabolite could be identified by this database using *m/z* value and retention time; \*, means that the metabolite could be identified by *m/z* value but not be identified by retention time.
